Shares Outstanding Shares Outstanding n/a Close	1.74B
Shares Change (YoY) Shares Change (YoY) n/a Close	-0.31%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	-0.01%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	77.56%
Shares Floating Shares Floating n/a Close	n/a
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	244
FTD / Avg. Volume FTD / Avg. Volume n/a Close	n/a

Short Selling Information

The latest short interest is 22.26M, so 1.28% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	22.26M
Short % of Shares Out Short % of Shares Out n/a Close	1.28%
Short % of Float Short % of Float n/a Close	1.29%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	3.47

Valuation Ratios

The PE ratio is 14.62 and the forward PE ratio is 23.41. Abbott Laboratories's PEG ratio is 0.11.

PE Ratio PE Ratio n/a Close	14.62
Forward PE Forward PE n/a Close	23.41
PS Ratio PS Ratio n/a Close	4.67
Forward PS Forward PS n/a Close	3.9
PB Ratio PB Ratio n/a Close	4.11
P/FCF Ratio P/FCF Ratio n/a Close	30.84
PEG Ratio PEG Ratio n/a Close	0.11

Financial Ratio History

Enterprise Valuation

Abbott Laboratories has an Enterprise Value (EV) of 203.28B.

EV / Sales EV / Sales n/a Close	4.85
EV / EBITDA EV / EBITDA n/a Close	18.76
EV / EBIT EV / EBIT n/a Close	23.75
EV / FCF EV / FCF n/a Close	32.01

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.32.

Current Ratio Current Ratio n/a Close	1.67
Quick Ratio Quick Ratio n/a Close	1.23
Debt / Equity Debt / Equity n/a Close	0.32
Debt / EBITDA Debt / EBITDA n/a Close	1.39
Debt / FCF Debt / FCF n/a Close	2.37
Interest Coverage Interest Coverage n/a Close	12.21

Financial Efficiency

Return on Equity is 28.12% and Return on Invested Capital is 18.97%.

Return on Equity Return on Equity n/a Close	28.12%
Return on Assets Return on Assets n/a Close	16.46%
Return on Invested Capital Return on Invested Capital n/a Close	18.97%
Revenue Per Employee Revenue Per Employee n/a Close	$367,982.46
Profits Per Employee Profits Per Employee n/a Close	$117,561.4
Employee Count Employee Count n/a Close	114,000
Asset Turnover Asset Turnover n/a Close	0.52
Inventory Turnover Inventory Turnover n/a Close	3.02

Taxes

Income Tax Income Tax n/a Close	-6.39B
Effective Tax Rate Effective Tax Rate n/a Close	-91.1%

Stock Price Statistics

The stock price has increased by 28.25% in the last 52 weeks. The beta is 0.74, so Abbott Laboratories's price volatility has been higher than the market average.

Beta Beta n/a Close	0.74
52-Week Price Change 52-Week Price Change n/a Close	28.25%
50-Day Moving Average 50-Day Moving Average n/a Close	130.88
200-Day Moving Average 200-Day Moving Average n/a Close	122.38
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	55.66
Average Volume (20 Days) Average Volume (20 Days) n/a Close	7,160,352

Income Statement

In the last 12 months, Abbott Laboratories had revenue of 41.95B and earned 13.4B in profits. Earnings per share was 7.74.

Revenue Revenue n/a Close	41.95B
Gross Profit Gross Profit n/a Close	23.24B
Operating Income Operating Income n/a Close	6.83B
Net Income Net Income n/a Close	13.4B
EBITDA EBITDA n/a Close	10.83B
EBIT EBIT n/a Close	7.57B
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	7.74

Full Income Statement

Balance Sheet

The company has 7.62B in cash and 15.02B in debt, giving a net cash position of -7.41B.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	7.62B
Total Debt Total Debt n/a Close	15.02B
Net Cash Net Cash n/a Close	-7.41B
Retained Earnings Retained Earnings n/a Close	47.26B
Total Assets Total Assets n/a Close	81.45B
Working Capital Working Capital n/a Close	10.15B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.56B and capital expenditures -2.21B, giving a free cash flow of 6.35B.

Operating Cash Flow Operating Cash Flow n/a Close	8.56B
Capital Expenditures Capital Expenditures n/a Close	-2.21B
Free Cash Flow Free Cash Flow n/a Close	6.35B
FCF Per Share FCF Per Share n/a Close	3.67

Full Cash Flow Statement

Margins

Gross margin is 55.41%, with operating and profit margins of 16.27% and 31.95%.

Gross Margin Gross Margin n/a Close	55.41%
Operating Margin Operating Margin n/a Close	16.27%
Pretax Margin Pretax Margin n/a Close	16.72%
Profit Margin Profit Margin n/a Close	31.95%
EBITDA Margin EBITDA Margin n/a Close	25.83%
EBIT Margin EBIT Margin n/a Close	16.27%
FCF Margin FCF Margin n/a Close	15.14%

Dividends & Yields

ABT pays an annual dividend of $2.83, which amounts to a dividend yield of 1.81%.

Dividend Per Share Dividend Per Share n/a Close	$2.83
Dividend Yield Dividend Yield n/a Close	1.81%
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	7.27%
Payout Ratio Payout Ratio n/a Close	36.8%
Earnings Yield Earnings Yield n/a Close	6.84%
FCF Yield FCF Yield n/a Close	3.24%

Dividend Details

Analyst Forecast

The average price target for ABT is $145, which is 8.4% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$145
Price Target Difference Price Target Difference n/a Close	8.4%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	16

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	$193.5
Lynch Upside Lynch Upside n/a Close	44.69%
Graham Number Graham Number n/a Close	69.23
Graham Upside Graham Upside n/a Close	-48.23%

Stock Splits

The last stock split was on Jan 2, 2013. It was a forward split with a ratio of 5000:2399.

Last Split Date Last Split Date n/a Close	Jan 2, 2013
Split Type Split Type n/a Close	forward
Split Ratio Split Ratio n/a Close	5000:2399

Scores

Altman Z-Score Altman Z-Score n/a Close	6.07
Piotroski F-Score Piotroski F-Score n/a Close	5